Germany’s Merck to buy Bio-Techne for $73 per share

Merck KGaA has agreed to acquire ‌biotech firm Bio-Techne Corp for $73 per share in cash, ⁠the German science and healthcare firm said in a statement on Thursday.Read More

What's Trending

When the U.S. and Canada had a beer battle

When the U.S. and Canada had a beer battle

What the world can learn from Uruguay as the global housing crisis deepens

National teacher certification must comply with Texas’ anti-DEI law

The global battle for Italian citizenship rights just got a potential lifeline

Tennessee gubernatorial candidates’ TV ads face criticism for promoting policies already in state law

Can you be too old to serve on a jury in SC? Here’s what the law says

Trump sued hours after new tariffs take effect, as experts say they may not hold up

Germany’s Merck to buy Bio-Techne for $73 per share

Kaepernick, Springsteen receive new ACLU award for activism in arts, business, science and sports

PILOT applications not necessarily reserved for primary sector businesses

F1 needs better balance between business and sport, says Norris

The next chapter: My 50th reunion at Harvard Business School

Leave A Reply Cancel Reply

What's Trending

Germany’s Merck to buy Bio-Techne for $73 per share

Related Posts

Leave A Reply Cancel Reply

Subscribe to MGSN